secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2021-11-15T23:59:59+00:00
Accession:  0001213900-21-059448
Event type: earnings
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx held Q3 2021 earnings call but transcript excerpt lacks financial details
--------------------------------------------------------------------------------

- Conference call held on November 9, 2021 to discuss quarterly results.
- Transcript attached as Exhibit 99.1, but provided text does not contain specific financial data.
- No revenue, EPS, or guidance figures available from the exhibit excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021059448/0001213900-21-059448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021059448/ea150503-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-059448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer